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ABSTRACT
Introduction. Angiography headache is defined as a new headache caused directly by cerebral angiography. We aimed to 
investigate the prevalence and clinical characteristics of angiography headache, and its relationship with primary headaches.
Material and methods. This single-centre prospective cohort study was carried out in our tertiary healthcare centre. Patients 
who had undergone a diagnostic cerebral angiography procedure between March 2016 and June 2017 were included in the 
study. During and after the procedure, we evaluated the patients in terms of occurrence of headache, and, if present, details 
about time to onset of headache after cerebral angiography, duration of headache, accompanying symptoms (nausea, vomiting, 
photophobia and phonophobia), and degree and severity of pain.
Results. A total of 226 patients were included in the study. The prevalence of angiography headache was found to be 22.1% 
(n = 50). While angiography headache started in the first six hours in 92% (n = 46) of the patients, it started after 24 hours of 
the angiography procedure in only 4% (n = 2). Compressive headache was the most common type, described by 64% of the 
patients, whereas 4% of the patients described pricking or stabbing sensations. Angiography headache was associated with 
female gender, higher educational level, and a history of primary headache.
Conclusion. Angiography headache is an important clinical entity that must be considered during and after angiography. 
Experiencing angiography headache is more common among patients with a history of primary headache.
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Introduction
Digital subtraction angiography (DSA) is an extremely 
important invasive method used frequently for the diagnosis, 
treatment and follow-up of cerebrovascular diseases. However, 
various complications such as intracerebral haemorrhage, 
ischaemic stroke, angina pectoris, seizures, headache, inguinal 
haematoma, pneumonia, retroperitoneal haemorrhage, femo-
ral arteriovenous fistula, and contrast-induced complications 
can occur after DSA. Headache after cerebral angiography is 
defined as an “angiography headache (AH)” under the topic 
“Headache attributed to other acute intracranial arterial dis-
order” in section 6.7.2 of the third edition of the International 
Classification of Headache Disorders (ICHD-3). Accordingly, 
AH is described as a new headache caused directly by cerebral 
angiography in cases where the headache meets at least two 
of the following criteria: 1) Headache developing during or 
within 24 hours of angiography procedure; 2) resolves within 
72 hours after the end of angiography; and 3) manifests as 
one of the following: a) developing during contrast injection 
and lasts for < 1 hour; b) developing a few hours after the an-
giography and lasting > 24 hours; c) occurs in a patient with 
migraine and having the features of 1.1 Migraine without aura 
or 1.2 Migraine with aura [1]. 
Numerous studies have been conducted to evaluate the 
headaches associated with endovascular procedures as well as 
the effects of non-ruptured aneurysms or non-haemorrhagic 
arteriovenous malformations (AVMs) on headache [2–6]. 
However, studies evaluating the relationship between DSA 
and headache have been limited. 
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This study aimed to determine the prevalence, risk factors, 
and clinical characteristics of AH, and its relationship with 
primary headaches.
Material and methods
This single-centre prospective cohort study was carried 
out in our tertiary healthcare centre in Adana, Turkey after ob-
taining the approval of the local ethics committee (Cukurova 
University, Faculty of Medicine, Ethics Committee for Non-
-invasive Clinical Research -Decision No: 78-2016). The stan-
dard practices in our centre facilitated the study: experienced 
interventional neuroradiologists regularly perform DSA for 
the diagnosis and treatment of cerebrovascular diseases. After 
the procedure, patients are followed in the neurology clinic 
or in the day-patient clinic for at least 12 hours. Patients are 
discharged if they develop no major complications. If a major 
complication such as AH develops, patients are observed in 
the neurology clinic for at least 24 hours.
Participants
Patients who had undergone a diagnostic DSA procedure 
between March 2016 and June 2017 were included in the study 
provided they were aged ≥ 18 years, conscious, mentally and 
cognitively normal, and had given written informed consent. 
In addition, patients with carotid or vertebral artery stenosis 
identified by DSA but who had not undergone endovascular 
treatment were also included. 
Study exclusion criteria were: having been diagnosed with 
intracranial mass, intracranial haemorrhage (primary intra-
cerebral haemorrhage, subarachnoid haemorrhage (SAH)), 
acute ischaemic stroke, intracranial aneurysm, AVM, disorders 
of consciousness, aphasia, moderate-to-severe dementia, and 
mental retardation.
Data collection
Information regarding the history of neurological diseases 
(e.g. epilepsy, Parkinson’s disease, demyelinating diseases, 
neuromuscular disease), alcohol consumption, smoking, 
body-mass index (BMI), hypertension, diabetes mellitus (DM), 
hyperlipidemia, and history of head trauma (and the typical 
symptoms, if any) before DSA was recorded. The details about 
duration of radiation exposure during DSA, total radiation 
dose received, amount of radiation to the body surface area 
(dose/m2), blood pressure before and after the procedure, as 
well as pulse rate, respiratory rate, and oxygen saturation (by 
pulse oximeter) were also recorded.
Monitoring protocol for angiography headache
A temporary increase in body temperature can occur after 
contrast substance injection. This is known as ‘flushing’ and 
can involve the head and the face. All patients were infor-
med about this probable situation so as to help distinguish 
a potential AH from this phenomenon. During and after the 
procedure, we evaluated the patients in terms of the occur-
rence of headache and, if present, details about time to onset 
of headache after DSA, duration of headache, accompanying 
symptoms (nausea, vomiting, photophobia and phonopho-
bia), and the degree and severity of pain. A visual analogue 
scale (VAS) was used to assess the severity of headache. All 
patients were evaluated for the development of AH within 
the first 72 hours. Those discharged before 72 hours were 
contacted by phone.
Angiography procedure
DSA procedure was performed in all patients using the 
same angiography device (Artis zee biplane, Siemens Health-
care, Forchheim, Germany) by an experienced interventional 
neuroradiologist after preparing appropriate sterile packs and 
the access site. For local anaesthesia, a prilocaine 2% inject-
able solution was used in all patients. The main femoral artery 
(preferably the right femoral artery, the left if the right was 
not available) was accessed using a 5Fr femoral introducer. All 
patients underwent a standard cerebral angiography procedure 
where iopromide 370 mg/mL (Ultravist® 370, Schering) was 
used as the opaque substance. We performed arcus aortogra-
phy and bilateral selective carotid, cerebral and vertebral an-
giography procedures. The entire cerebral venous system was 
visualised. After the procedure, the introducer was removed 
and tight compression was applied. Patients who had been 
immobilised for six hours were monitored and followed in the 
neurology clinic. Using the exam protocol software available 
on the post-treatment angiography device, total radiation 
exposure was recorded as the radiation dose per square metre 
of body surface area.
Statistical analysis
Statistical analyses of data were performed using IBM® 
SPSS® for Windows software (Version 20.0, IBM, Armonk, 
NY, USA). Categorical variables were presented as number 
and percentages, whereas continuous variables were presented 
as mean and standard deviation. Chi-square test was used for 
the comparison of categorical variables between the groups. 
Comparison of continuous variables between the groups was 
done by Student’s t-test. Statistical significance was predeter-
mined to be p < 0.05 for all tests.
Results
Participants
A total of 226 patients were included in the study. The 
frequency of AH was found to be 22.1% (n = 50). There was 
an equal gender distribution (50.9% females). However, AH 
was more prevalent in females (27% vs 17.1%) (p = 0.007). 
The mean age of the patients was 57.2 ± 13.32 years (range 
18–82), and it was lower in the patients with AH (53.02 
± 12.21) compared to the patients without AH (58.39 ± 13.41) 
(p = 0.007) (Tab. 1).
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Relevant pre-DSA history
Educational status was directly correlated to the frequency 
of AH. While most of the illiterate patients did not report AH 
(92.3% were asymptomatic), many secondary school graduates 
complained about AH (32.7% were symptomatic) (Tab. 1).
The most common comorbidity was hypertension (61.5%). 
By contrast, only 4% had a history of neurological diseases 
including Parkinson’s disease (n = 4), epilepsy (n = 4) and 
polyneuropathy (n = 1). Only two of these patients developed 
AH; no significant relationship was determined between AH 
and the presence of history of stroke and primary neurological 
diseases other than primary headache. Overall, 26.9% (n = 61) 
of the participants reported primary headache diagnosed before 
DSA, and AH was found to be more frequent in these patients 
compared to those without primary headache (40% vs 18.2%; p 
= 0.01). Of the patients with AH, 32% (n = 16) had tension-type 
headache and 8% (n = 4) had migraine before DSA (Tab. 1).
Presentation of angiography headache
The vital signs of the patients with and without headache 
were compared before and after the DSA procedure. Heart 
rate was significantly lower before the procedure in those with 
headache, but there was no significant difference in terms of 
other vital signs. In addition, duration of radiation exposure, 
total amount of radiation, and amount of radiation to body 
surface area (dose/m2) were not significantly different between 
patients with AH and non-AH patients (Tab. 2).
While AH started in the first six hours in 92% (n = 46) of 
the patients, it started after 24 hours of the DSA procedure 
in only 4% (n = 2). Compressive headache was the most 
common type described by 64% of the patients, whereas 4% 
of the patients described pricking or stabbing sensations. 
Twenty-six percent (n = 13) of the patients with AH had 
accompanying symptoms (nausea in eight, photophobia in 
five, phonophobia in five and vomiting in four). Duration of 
headache was less than six hours in 90% and less than three 
hours in 78% of the patients. None of the patients reported 
a headache lasting longer than 24 hours. The percentages of 
the patients with bilateral and unilateral headache were 76% 
and 24%, respectively. Orbito-frontal region was the most 
common localisation, whereas the least common was the 
cervical region. With regard to the severity of pain, the mean 

















































BMI [kg/m2] (mean ± SD) 27.48 ± 4.68 28.25 ± 5.17 28.07 ± 5.07 0.34
HTN 30 (21.6) 109 (61.9) 139 (61.5) 0.87
DM 10 (15.4) 55 (31.3)  65 (28.8) 0.15
Hyperlipidemia 17 (26.2) 48 (27.3)  65 (28.8) 0.35
Stroke history  17 (34) 53 (30.3)  70 (31) 0.6
Head trauma history  8 (16)  14 (8) 22 (9.7) 0.09
Currently smoking 16 (24.2) 50 (28.4)  66 (29.2) 0.6
Alcohol consumption  2 (4)  10 (5.7)  12 (5.3) 0.6
Neurological disease  2 (4)  7 (4) 9 (4) 0.9
Primary headache  20 (40)  30 (18.2)  50 (22.1) 0.01
AH — angiography headache; BMI — body mass index; DM — diabetes mellitus; HTN — hypertension; SD — standard deviation 
445www.journals.viamedica.pl/neurologia_neurochirurgia_polska
Turgay Demir et al., Clinical features and risk factors of angiography headache




 (n = 50) 




































Radiation exposure time [min] 8.49 ± 5.3 9.1 ± 7 8.29 ± 4.64 0.48
Total radiation dosage [µGy] 666.4 ± 265.7 697.8 ± 283.1 656.6 ± 256 0.47





AH — angiography headache; DBP — diastolic blood pressure; DSA — digital subtraction angiography; SBP — sistolic blood pressure; SD — standard deviation
VAS score was 5.36 ± 1.87, with headache severity defined 
usually as moderate (Tab. 3).
Angiography headache and previous primary 
headache 
The mean age of patients with AH and migraine was 44 
± 9.81 years (range 35–56), whereas the mean age of patients 
with AH and tension-type headache was 59.12 ± 8.49 years 
(range 45–72) (p = 0.006).
Of the 61 patients with a diagnosis of primary headache, 
32.8% developed AH. However, there was no significant re-
lationship in these patients between AH and gender, diabetes 
mellitus, hypertension, hyperlipidemia, history of stroke, 
neurological disease other than primary headache, stroke, 
alcohol consumption, smoking, blood pressure, pulse rate, 
respiratory rate, presence of fever before DSA procedure, 
oxygen saturation, or radiation dose per square metre of body 
surface. Development of AH was associated with duration 
of radiation exposure (p = 0.04). Patients with a history of 
primary headache who developed AH had lower body mass 
index, higher educational level, and head trauma history more 
often than patients without AH, but the difference was not 
statistically significant (Tab. 4). 
Discussion
In this study, the frequency of AH was 22.1%, which is con-
sistent with the wide range of frequencies (0.3–51%) reported 
in earlier studies [7–9]. Although Heiserman et al. [8] reported 
a relatively low rate of headache (0.3%) in the first six hours 
after DSA procedure in a sample of 1,000 patients, they did not 
evaluate AH in detail, only the neurological complications. The 
incidence of AH was 30.2% in a case-control study performed 
by Aktan et al. [10] in 139 patients, whereas it was much 
higher (55.6%) in a retrospective study conducted by Kwon et 
al. [11]. The differences between these studies in terms of the 
frequency of AH might result from methodological (patient 
characteristics) differences or from the inclusion of patients 
with intracerebral aneurysm or SAH, which we excluded.
History of headache before the procedure, female gender, 
cerebrovascular disease and educational status have all been 
reported to be risk factors for developing AH [7, 12, 13]. In 
our study, female gender, educational status, and history of 
primary headache were associated with AH. AH was more 
prevalent in the females in our cohort (27% vs 17.1%, p = 0.08), 
which is consistent with findings reported by Kwon et al. [11] 
and with the results of the study conducted by Gil-Gouveia 
et al. [7], who reported female gender to be a risk factor for 
AH. Lower awareness about headache in patients with a lower 
educational level might explain the finding of the association 
between higher education and AH. 
The mechanism of developing AH remains unclear despite 
the fact that hormones, vasoactive substance (e.g. nitric oxide 
or serotonin) release induced by catheter placement or contrast 
substances, or mechanically stressed veins in individuals with 
a sensitive trigeminovascular nociceptive system have all been 
deemed responsible [7, 8, 12, 14].
In our study, the characteristics of AH were as follows: it 
started in the first six hours after the DSA procedure in 92%, 
was compressive and moderate in 64% and bilateral in 76%, 
and had accompanying symptoms such as nausea, vomiting, 
photophobia and phonophobia in 26%. Aktan et al. [10] 
identified two types of headache starting either during or after 
the procedure. In the former, the headache starts immediately 
after the administration of the contrast substance and lasts no 
longer than 30 minutes. It is also associated with the sensation 
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Table 3. Clinical characteristics of angiography headache
Characteristics Angiography headache 
(n = 50) 
n (%)

























































SD — standard deviation; VAS — visual analogue scale 
of pressure or pulsatile character with no accompanying symp-
toms (i.e. nausea, vomiting, photophobia or phonophobia). In 
the latter, headache occurs in the first 24 hours after the pro-
cedure. It usually develops 2–10 hours after DSA, disappears 
within three hours of onset, shows a bilateral fronto-temporal 
or a generalised localisation, is of mild–moderate severity, and 
has a pulsatile character. 
This second type of AH has been reported to be more 
prevalent in patients with a history of primary headache; in 
the present study, this type of headache occurred in the first 
six hours in 92% of cases and was more frequently associated 
with bilateral localisation and moderate severity [10]. Ho-
wever, most of our patients had tension-type headache, and 
migraine headache was less common. 
We concluded that this may be associated with the higher 
mean age of AH patients with a history of tension-type heada-
che compared to those with a history of migraine, particularly 
females. A history of primary headache is associated with AH, 
as has been reported in earlier studies [7, 10–12].
Most studies in the literature have emphasised that AH is 
common in those with primary headache. Literature studies 
evaluating AH in detail in patients with primary headache are 
few. The present study is the first to evaluate AH in patients 
with primary headache. Education, BMI, history of head 
trauma, and duration of radiation exposure were found to play 
a critical role in the development of AH in patients with pri-
mary headache. The prevalence of AH may be associated with 
a low pain threshold in patients with primary headache and 
higher education. The prolonged duration of DSA procedure 
also increases the duration of radiation exposure. Patient stress 
is also increased with prolonged duration of DSA procedure. 
The duration of radiation exposure might be associated with 
increased stress, which is high in patients with AH.
According to the ICHD-3, AH needs to be more diffu-
se, severe and migrainous in patients with migraine [1]. Of 
the 61 patients with a history of primary headache, 29.5% 
(n = 18) had a history of migraine and only 22.2% (n = 4) of 
these patients developed AH. Our patients typically described 
AH as a tension-type headache with diffuse localisation. AH was 
defined as migrainous in two of these patients. Sixteen patients, 
who had been previously diagnosed with tension-type headache, 
developed AH. In contrast to the literature, we therefore showed 
that AH is more likely to occur in patients having tension-type 
headache before DSA, and that the AH itself is likely to manifest 
as a tension-type headache. This is probably associated with 
the anxiety and stress experienced by the patients before the 
procedure, which is confirmed by increased blood pressure 
prior to the procedure determined even in the patients without 
documented hypertension. However, the headache described by 
these patients after the procedure did not have the characteristics 
of a typical hypertensive vascular headache. Such headaches 
also did not occur in patients with high blood pressure before, 
during or after the procedure who developed AH.
The ICHD-3 defines the headache associated with radia-
tion as “headache attributed to radiosurgery of the brain” [1]. 
However, no published study has evaluated the relationship 
between radiation and headache in patients who had under-
gone DSA. This indicates that the present study is the first to 
evaluate such a relationship. 
We determined that there was no significant relationship 
between the occurrence of AH and radiation dose to the 
head, duration of radiation exposure, total radiation dose, or 
radiation dose to body surface area.
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History of head trauma 6 (30)  4 (9.8)  43 (67.2) 0.06


















Prophylactic treatment of PH 5 (38.5)  8 (61.5) 13 (21.3) 0.74
Duration of radiation [min] 
 (mean ± SD)
9.8 ± 7.3  6.25 ± 3.51 0.04
AH — angiography headache; BMI — body mass index; PH — primary headache; SD — standard deviation
The relationship between pre-DSA vital signs and deve-
loping AH has not been previously evaluated. In the present 
study, we showed that there is a relationship between the 
development of AH and either a low pulse rate or a history of 
headache before the procedure. To date, most studies about 
AH have considered only the headaches that occurred during 
or after the endovascular procedures. Some of these studies 
considered patients with aneurysm or AVM in the SAH group, 
or considered patients with stenosis in the carotid/vertebral 
artery stenosis group. 
By contrast, in the present study, we excluded patients 
with SAH, AVM, aneurysm and carotid or vertebral artery 
stents because headaches due to intracerebral haemorrhage 
or due to an endovascular procedure could interfere with the 
presentation of AH. 
In addition, symptomatic headaches that develop during 
angiography should also be kept in mind. Symptomatic hea-
daches due to situations such as vasodilatation of meningeal 
arteries, posterior reversible encephalopathy syndrome, and 
also cerebral hyperperfusion syndrome after carotid interven-
tions, have been reported in the literature [15–17]. 
Conclusions
AH is an important clinical entity that must be considered 
during and after DSA. However, we found distinct and novel 
characteristics indicating that AH is associated with moderate 
severity, compressive character, and duration of less than six 
hours. Experiencing AH is more common among patients with 
a history of primary headache. Studies on this topic, and the 
classifications, remain inadequate in evaluating some clinical 
pictures. It would be beneficial to set up better structured 
studies with larger patient series based on the current data. 
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